Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Applied DNA Sciences Inc. (APDN:NASDAQ), powered by AI.
Applied DNA Sciences Inc. is currently trading at $0.54. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Applied DNA Sciences Inc. on Alpha Lenz.
Applied DNA Sciences Inc.'s P/E ratio is -0.0.
“Applied DNA Sciences Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -99.2%.”
Ask for details →Applied DNA Sciences Inc. operates as a biotechnology company focused on developing and commercializing DNA-based technologies. The company’s primary function is to provide molecular tagging and authentication solutions across a variety of industries. This includes securing supply chains and enhancing product authenticity in sectors such as pharmaceuticals, textiles, and personal care products. Applied DNA Sciences employs proprietary technologies that allow for unique DNA markers to be embedded into materials, enabling precise tracking and verification throughout the production and distribution process. This enhances transparency and trust, mitigating risks associated with counterfeiting and fraud. Beyond supply chain security, the company is actively involved in advancing DNA-based solutions in the medical diagnostics field, contributing to developments in genetic analysis and forensic science. Headquartered in Stony Brook, New York, Applied DNA Sciences plays a vital role in integrating biotechnology advancements into everyday industrial applications, reinforcing the importance of traceability and reliability in global markets.
“Applied DNA Sciences Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -99.2%.”
Ask for details →Applied DNA Sciences Inc. (ticker: APDN) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 46 employees. Market cap is $57,533.
The current price is $0.544 with a P/E ratio of -0.01x and P/B of 0.01x.
ROE is -99.23% and operating margin is -408.72%. Annual revenue is $3M.